SCHEMBL1630306

SCHEMBL1630306

COc1cc(OC)c(-c2ccnn2-c2ccccc2[N+](=O)[O-])cc1I

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.41
▸ TDP1 Q9NUW8 3/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ ACHE P22303 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ NR3C2 P08235 1/20 0.37
▸ PTK2 Q05397 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ MAPK1 P28482 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6448483 0.84 ALDH1A1 (0.50) ALDH1A1TDP1ACHEBACE1MAPT
SCHEMBL1630525 0.82 HSP90AA1 (0.44) ALDH1A1HSP90AA1MEN1KMT2AL3MBTL1
SCHEMBL1219068 0.82 HSP90AA1 (0.45) ALDH1A1HSP90AA1MAPTNR3C2NPSR1
SCHEMBL1629564 0.81 HSP90AA1 (0.44) ALDH1A1HSP90AA1MAPTNR3C2MAPK1
SCHEMBL1631531 0.81 HSP90AA1 (0.62) HSP90AA1MAPTNR3C2SMN1; SMN2
SCHEMBL5171042 0.80 ALDH1A1 (0.37) ALDH1A1TDP1HSP90AA1ACHEBACE1
SCHEMBL1629833 0.80 POLB (0.40) TDP1ACHEBACE1MAPTMEN1
SCHEMBL1631623 0.79 P2RX7 (0.42) HSP90AA1MAPTNR3C2
SCHEMBL1629555 0.78 PDE10A (0.48) ALDH1A1HSP90AA1MAPTMEN1KMT2A
SCHEMBL1630476 0.77 MAPT (0.45) ALDH1A1HSP90AA1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 — — US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P ALDH1A1 777/4885TDP1 722/4885HSP90AA1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback